Sign inGet started

Kropotova Alexandra

Insider CIK 1825323 · IBIO Director · SABS Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IBIO iBio, Inc. A Award deriv2026-10-142026-10-1538,000— $038,000SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2026-09-172026-09-18473— $041,853SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2026-09-172026-09-18473— —41,853SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2026-06-252026-06-26988— $042,308SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2026-03-242026-03-25988— $043,296SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2026-02-032026-02-052,400,000— $02,400,000SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2025-12-112025-12-12988— $044,284SEC↗
IBIO iBio, Inc. A Award deriv2025-11-202025-11-2413,500— $013,500SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2025-09-192025-09-221,977— $045,272SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2025-08-262025-08-282,400,000— $02,400,000SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2025-03-272025-04-011,179— $047,249SEC↗
SABS SAB Biotherapeutics, Inc. F Tax w/h2024-12-182024-12-319,072— $048,428SEC↗
IBIO iBio, Inc. A Award deriv2024-11-212024-11-2518,900— $018,900SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2024-02-212024-02-23140,000— $0140,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award2023-03-142023-03-16275,000— $0275,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2022-09-132022-09-1518,325— $018,325SEC↗
SABS SAB Biotherapeutics, Inc. A Award2022-06-062022-06-07300,000— $0300,000SEC↗
IBIO iBio, Inc. A Award deriv2021-12-092021-12-13109,000— $0109,000SEC↗
IBIO iBio, Inc. A Award deriv2020-10-142020-10-16100,000— $0100,000SEC↗